Related Experiment Video
Updated: Aug 5, 2026

05:51
Assessing the Accuracy of Fitness Smartwatch Data for Cardiovascular and Physical Activity Monitoring: A Validation Study in Digital Health
Published on: February 21, 2025
Real-World Walking Patterns From Wrist-Worn Wearables Predict Incident Type 2 Diabetes: A UK Biobank WatchWalk Study
Carlota Lisset Toapanta Gaibor1,2, Silvia Bellés Andreu1,2, Stephen R Lord2,3
1Department of Geriatrics, Hospital Clínic de Barcelona, University of Barcelona, Spain.
Journal of Diabetes Science and Technology
|July 28, 2026
Summary
Digital gait biomarkers from wearable devices can predict type 2 diabetes (T2D) risk. These real-world walking patterns improve risk identification beyond traditional factors.
Area of Science:
- Biomedical Engineering
- Epidemiology
- Metabolic Health
Background:
- Type 2 diabetes (T2D) poses a significant global health challenge.
- Early identification of individuals at risk for T2D is crucial for effective prevention.
- Wearable technology offers novel opportunities for objective health monitoring.
Purpose of the Study:
- To investigate the association between digital gait biomarkers and incident T2D.
- To determine if gait characteristics improve T2D risk prediction beyond established factors.
Main Methods:
- Analysis of UK Biobank data from 71,618 participants without diabetes.
- Derivation of gait biomarkers (walking speed, quality, duration) from wrist accelerometer data.
- Cox proportional hazards models and C-index used for risk assessment and model discrimination.
Main Results:
- Slower walking speed, shorter walking bouts, and lower daily running duration were independently associated with increased T2D risk.
- A model incorporating gait biomarkers and traditional risk factors achieved a C-index of 0.80.
- This combined model outperformed models using only traditional risk factors or step counts.
Conclusions:
- Real-world gait patterns measured by wearables are independently associated with incident T2D.
- Digital gait biomarkers enhance the accuracy of identifying individuals at risk for T2D.
- Gait biomarkers may reflect early metabolic vulnerability, aiding in risk stratification and prevention.

